Isavuconazole for treatment of rare invasive fungal diseases-Reference-Cited by-同舟云学术

Isavuconazole for treatment of rare invasive fungal diseases

Published:2018-07-24 Issue:8 Volume:61 Page:518-533
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Cornely Oliver A.¹^ORCID,Mullane Kathleen M.²,Ostrosky-Zeichner Luis³,Maher Rochelle M.⁴,Croos-Dabrera Rodney⁴,Lu Qiaoyang⁴,Lademacher Christopher⁴,Perfect John R.⁵,Oren Ilana⁶,Schmitt-Hoffmann Anne-Hortense⁷,Giladi Michael⁸,Marty Francisco M.⁹^ORCID,Rahav Galia¹⁰

Affiliation:

1. Department I of Internal Medicine; Clinical Trials Centre Cologne; ZKS Köln; and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD); University of Cologne; Cologne Germany

2. Department of Medicine/Section of Infectious Diseases and Global Health; University of Chicago; Chicago IL USA

3. University of Texas Medical School at Houston and Memorial Hermann Texas Medical Center; University of Texas; Houston TX USA

4. Astellas Pharma Global Development, Inc.; Northbrook IL USA

5. Department of Medicine/Division of Infectious Diseases; Duke University; Durham NC USA

6. Unit of Infectious Diseases; Rambam Health Care Campus; Haifa Israel

7. Basilea Pharmaceutica International Ltd; Basel Switzerland

8. Infectious Disease Unit; Tel Aviv Sourasky Medical Center; and The Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv Israel

9. Division of Infectious Diseases; Brigham and Women's Hospital; Boston MA USA

10. Infectious Disease Unit; Sheba Medical Center; Tel Hashomer; and The Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv Israel

Funder

Astellas Pharma US

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/myc.12778/fullpdf

Reference53 articles.

1. Population-based analysis of invasive fungal infections, France, 2001-2010;Bitar;Emerg Infect Dis,2014

2. Fusarium: molecular diversity and intrinsic drug resistance;Al-Hatmi;PLoS Pathog,2016

3. Current antifungal treatment of fusariosis;Al-Hatmi;Int J Antimicrob Agents,2018

4. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases;Cornely;Clin Microbiol Infect,2014

5. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013;Cornely;Clin Microbiol Infect,2014

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of isavuconazole on the pharmacokinetics of sunitinib and its mechanism;BMC Cancer;2024-09-11

2. A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole;Medical Mycology;2024-08-13

3. In vitro evaluation of antifungal combinations against neurotropic dematiaceous fungi associated with primary cerebral phaeohyphomycosis;Microbiology Spectrum;2024-08-06

4. Pharmacokinetics of isavuconazonium sulfate and its active metabolite isavuconazole in healthy dogs;PLOS ONE;2024-07-16

5. Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections;Clinical Microbiology Reviews;2024-06-13